Urine Cytology

13
URINE CYTOLOGY KIPRONO FELIX H31/2244/2011 UNIVERSITY OF NAIROBI SUPERVISED BY DR NDUNG’U 25 TH JULY 2014

Transcript of Urine Cytology

Page 1: Urine Cytology

URINE CYTOLOGY

KIPRONO FELIX

H31/2244/2011

UNIVERSITY OF NAIROBI

S U P E RV I S E D BY D R N D U N G ’ U

2 5 T H J U LY 2 0 1 4

Page 2: Urine Cytology

A 58 year old man has a 3 month history of haematuria. He works in a dye factory and smokes 30 cigarettes per day for the last 25 years. He denies taking alcohol.

Discuss the role of urine cytology in diagnosis of his condition

What instruction will you give to the patient regarding collection of the urine and what precaution should be taken?

What type of bladder cancer is this gentleman likely to have and what are the predisposing factors? List other predisposing factors.

Discuss grading of bladder cancer.

Page 3: Urine Cytology

Introduction

Voided urine cytology is the standard noninvasive method for diagnosis in the detection of bladder carcinoma.

Cytology is used to assess morphologic changes in intact cells.

The test may also detect cancers of the kidney, ureter, prostate, and urethra.

Page 4: Urine Cytology

Role of urine cytology in diagnosis of conditions

Provides a timely and meaningful clinical information to the doctor as to what the patient is suffering from. This allows the doctor the advantage of investigating suspicious, possibly malignant disease process early in its course in the patient.

It is a simple, non-invasive and inexpensive technique that provides satisfaction and full cooperation from the patient.

Urine cytology will provide the information that aids the doctor in diagnosing the patient’s condition. It also provides a pathway for a more definitive diagnosis and subsequent choice of therapy

It is an adjunct to sophisticated direct-visualization urologic diagnostic techniques.

It supports diagnosis of infectious, inflammatory and neoplastic diseases of the urinary tract.

In this patient with high industrial exposure to carcinogens in dyes, urine cytology would be the initial test for screening and detection of bladder cancer

Page 5: Urine Cytology

Collection of urine for cytologyGood viable cellular content in urine is required for proper utilization of cytologic consultation.

The patient is to collect second morning voided urine

Wash and dry hands thoroughly

Midstream, clean-catch urine specimen is to be collected

Pass a small amount of urine into the toilet

Midway through micturition the patient is to fill the sterile collection container upto the desired level

Finish voiding into the toilet

Replace lid and tighten firmly

Wash and dry hands thoroughly after collection

Page 6: Urine Cytology

Precautions

First morning voided urine and twenty four hour urine should not be collected

The patient must ensure that they clean the area around the urethra to avoid contamination of the urine

sterile urine cup

Page 7: Urine Cytology

Bladder Cancer and Predisposing FactorsTransitional cell carcinoma (TCC) is the most common type of bladder

cancer. It is also known as urothelial carcinoma. Up to 5% of bladder

cancers are squamous cell in origin, and 2% are adenocarcinomas.

Therefore the most likely cancer that this patient could be suffering from

is transitional cell carcinoma of the bladder.

The risk factors that are associated with TCC in this patient are:

Working in a dye factory (aniline dyes and aromatic amines exposure)

Smoking 30 cigarettes in a day for 25 years. About 50% of all bladder

cancers may be caused by cigarette smoking. The longer and heavier the

exposure, greater are the chances of developing bladder cancer.

(nitrosamine & 4-aminobiphenyl

His male gender(M:F=4-1) Men are more prone to developing bladder

cancer compared to women

His age 55years old. About 90 percent of people with bladder cancer are

over age 55, (uncommon <50y)

Page 8: Urine Cytology

Other factors that predispose a person

to develop bladder cancer are:

Schistosomiasis infection

(S.haematobium)

Long term cyclophosphamide therapy

and radiatioin therapy

Bladder exstrophy & bladder

diverticular

Working in a rubber industry

NSAID abuse (paracetamol)

Family history of bladder cancer

cancers

ar

Page 9: Urine Cytology

Grading of bladder cancer

Grading of bladder cancer is a measure of the extent by which the tumor cells differ in their appearance from normal bladder cells. The greater the distortion of cellular appearance, the higher the grade the tumour is assigned. High-grade cancers are more aggressive than low-grade ones and have a greater propensity to invade into the bladder wall and metastasize.

Page 10: Urine Cytology

Grade I The cells of these bladder tumors resemble normal cells. They are thus low grade or well differentiated and tend to grow slowly and are not likely to spread.

Grade IIThere is a large variation in cell and nuclear sizes. They are medium grade and are moderately differentiated with more epithelial layers. They may grow or spread more quickly than low grade cancers

Grade IIIThe cells of these tumours have no resemblance to their cells of origin. They are poorly differentiated with breakdown of connection between the cells causing them to fragment hence highly metastatic.

They are often ulcerated and they penetrate through the bladder wall. They have the worst prognosis.

Page 11: Urine Cytology

various stages of bladder carcinoma

Low-grade, noninvasive papillary urothelial carcinoma

Low-grade, noninvasive papillary urothelial carcinoma

Various stages of bladder carcinoma

Page 12: Urine Cytology

World Health Organization

Bladder Cancer Grading (2004)

Urothelial papilloma - noncancerous (benign) tumor

Papillary urothelial neoplasm of low malignant potential

(PUNLMP) - slow growing and unlikely to spread

Low-grade papillary urothelial carcinoma - slow growing

and unlikely to spread

High-grade papillary urothelial carcinoma - more quickly

growing and more likely to spread

Page 13: Urine Cytology

References

Berry Schumann and Franklin Colon; The Clinicians Guide To Diagnostic

Cytology; Yearbook Medical Publisher.

specimencare.com

emedicine.medscape.com

THANK YOU!!